Know exactly how your molecule is doing across the NHS.
DoseTrend tracks prescribing and dispensing for the molecules you care about, in one dashboard, with a monthly briefing PDF attached. £1,500 a month per molecule, and yes, we just told you the price.
The market has expensive syndicated data at one end, and PDFs at the other.
If you make or market a molecule sold in England, you either pay six figures for syndicated data, or you scrape NHSBSA CSVs yourself on a Tuesday afternoon. Neither is a good use of your week.
DoseTrend sits between the two. Every open dataset the NHS publishes, cleaned, joined and charted for one molecule at a time. Priced so a product manager can sign it off without a procurement round.
One molecule. Every angle we can honestly show you.
-
A · Trend
Monthly items and spend, back to 2019, primary and secondary care in one series where the codes allow.Indexed views, YoY deltas, seasonality flags. The chart on your homepage, in your inbox, every month.
-
B · Geography
Every ICB, every practice, ranked and mapped.36 Integrated Care Boards, 7,299 GP practices. Filter by strength, formulation, indication where inferrable.
-
C · Hospital
SCMD data joined to primary care, so the picture is one picture.The two datasets use different vocabularies. We do the mapping once so you don't have to argue about it in a meeting.
-
D · Briefing
A monthly PDF written by a human, sent on the first working day.Two pages. What moved, why we think it moved, and what to watch next month. No dashboards to log into if you don't want to.
Built on open data, published in public.
Sources: NHSBSA English Prescribing Data (primary care), Secondary Care Medicines Data (hospital dispensing), NHS Digital ODS reference data. Used under the Open Government Licence v3.0.
What we won't pretend to show you.
Open data has limits and we'd rather you knew them before you pay us. For most generics you cannot see manufacturer-level brand share, because the NHS doesn't publish it. Some hospital data lags by four to six weeks. Some ICBs code the same drug three different ways and we have to make judgement calls. If you need what open data can't give you, you need a paid pharmaceutical data provider and their budget. If you need everything else, you need us.
One price. Written on the tin.
£1,500 a month per molecule. Unlimited users at your company. Annual pays twelve months for eleven. Portfolios from three molecules up.
Tell us the molecule.
Every applicant gets a five-minute call. About one in ten gets told this isn't for them on that call. It saves both of us a bad month.